NeuroSense receives Japanese patent for ALS drug candidate PrimeC
Go back to NeuroSense receives Japanese patent for ALS drug candidate PrimeC| (NASDAQ: NRSN) | Delayed: 0.73 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.73 | 52 Week High | $ | |||
| Open | $0.74 | 52 Week Low | $ | |||
| Day High | $0.74 | P/E | N/A | |||
| Day Low | $0.71 | EPS | $ | |||
| Volume | 24,609 | |||||
| (NASDAQ: NRSNW) | Delayed: 0.09 -0.04 (30.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.13 | 52 Week High | $ | |||
| Open | $0.08 | 52 Week Low | $ | |||
| Day High | $0.09 | P/E | N/A | |||
| Day Low | $0.08 | EPS | $ | |||
| Volume | 814 | |||||

